儿童重症监护室长时间住院的儿科患者的临床特征
Crisaixela Moya-Sánchez1, Isabel Znaya Ramírez-Flores2, Maria E Salazar-Rios1
1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría "Dr. Silvestre Frenk Freund", Departamento de Pediatría. Ciudad de México, México.
Revista medica del Instituto Mexicano del Seguro Social
|March 3, 2026
概括
在儿科重症监护室 (PICU) 长时间停留 (PLOS) 影响12.2%的儿童,消耗大量资源. 机械呼吸和器官置换疗法预测了PLOS,突出了针对性干预的需要.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 医疗保健资源利用情况 医疗保健资源利用情况
- 临床流行病学临床流行病学
背景情况:
- 在儿科重症监护室 (PICU) 长时间停留 (PLOS) 带来了重大的临床和经济挑战.
- 关于墨西哥PLOS的数据有限,需要进一步调查.
- 了解PLOS对于优化儿科重症监护资源配置至关重要.
研究的目的:
- 确定在PICU中患有PLOS的儿童的临床特征.
- 确定与长时间PICU停留相关的主要风险因素.
- 为改善儿科重症监护的结果和资源管理策略提供信息.
主要方法:
- 对重症儿童进行了一项回顾性队列研究.
- PLOS被定义为超过14天的PICU停留时间.
- 后勤回归分析确定了PLOS的独立预测因素.
主要成果:
- 12.2%的患者经历了PLOS,占PICU睡眠时间的47%.
- 与非PLOS患者 (8.1%) 相比,PLOS组的死亡率更高 (15.7%).
- 机械呼吸 (OR=2.37) 和/肝替代疗法 (OR=44.68) 是PLOS的显著预测因素.
结论:
- 患有PLOS的患者虽然少数,但不成比例地影响PICU资源.
- 早期识别患有PLOS风险的儿童对于资源优化至关重要.
- 针对PLOS患者的有针对性的护理策略可以改善临床结果和资源利用.
相关概念视频
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

